NCT02933840

Brief Summary

The purpose of this study is to determine the efficacy of a remote patient monitoring platform and alert system in reducing adverse events for hospitalized geriatric orthopedic trauma patients.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2017

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 12, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 14, 2016

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
Last Updated

October 31, 2019

Status Verified

October 1, 2019

Enrollment Period

Same day

First QC Date

October 12, 2016

Last Update Submit

October 29, 2019

Conditions

Outcome Measures

Primary Outcomes (4)

  • Mortality

    Whether a patient experiences death during their hospitalization.

    One year

  • Transfer to the ICU

    Whether the patient is transferred from a floor unit to the intensive care unit during their hospitalization.

    One year

  • Cardiac arrest

    Whether the patient experiences a cardiac arrest during their hospitalization.

    One year

  • Rapid response team called

    Whether the a rapid response team is called to assess the patient during their hospitalization.

    One year

Secondary Outcomes (15)

  • Time to ordering of blood

    One year

  • Time to ordering of fluids or vasopressors

    One year

  • Time to ordering of diuretics, NIPPV, or intubation

    One year

  • Time to ordering of nodal blocking agent

    One year

  • Time to ordering of insulin

    One year

  • +10 more secondary outcomes

Study Arms (2)

AlertWatch

EXPERIMENTAL

Patients will receive standard monitoring and in addition the AlertWatch software will alert the intensive care physician if there is a value that meets criteria for alerting. The care team will be the orthopedic surgery team in addition to the intensive care physician being involved as a consultant if he/she receives an alert.

Device: AlertWatch

No AlertWatch

NO INTERVENTION

Patients will receive standard monitoring without the AlertWatch software. The care team will be the orthopedic surgery team without the intensive care physician being involved as a consultant.

Interventions

AlertWatch holds 510(k) FDA clearance K15335. It is a software program that takes data present in the medical record, including vital signs and laboratory results, and determines whether it meets predetermined thresholds for alerting a clinician. These thresholds are intended to correlate with signs of acute clinical deterioration in the patient being monitored.

AlertWatch

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Admitted to Massachusetts General Hospital or Brigham and Women's Hospital
  • Admitted to orthopedic trauma surgery service
  • Admitted to a non-ICU bed (patients initially admitted to an ICU and then transferred to the non-ICU bed will be included)

You may not qualify if:

  • Admitted to service other than orthopedic trauma surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Fractures, BoneCardiovascular AbnormalitiesRespiratory System AbnormalitiesHemorrhage

Condition Hierarchy (Ancestors)

Wounds and InjuriesCardiovascular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Aalok V Agarwala, MD, MBA

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Division Chief of General Surgery Anesthesia, Associate Director of Quality and Safety

Study Record Dates

First Submitted

October 12, 2016

First Posted

October 14, 2016

Study Start

January 1, 2017

Primary Completion

January 1, 2017

Study Completion

January 1, 2017

Last Updated

October 31, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share